CRMD insider transactions
CorMedix Inc. (CRMD) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for CRMD
- Chief Legal Officer Zelnick Kaufman Beth was granted 36,006 shares, increasing direct ownership by 15% to 269,108 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Chief Executive Officer Todisco Joseph was granted 77,156 shares, increasing direct ownership by 11% to 774,749 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Chief Operating Officer Hurlburt Elizabeth was granted 36,006 shares, increasing direct ownership by 15% to 278,539 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Chief Financial Officer Blum Susan was granted 72,820 shares and covered exercise/tax liability with 9,767 shares, increasing direct ownership by 90% to 132,739 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Chief Legal Officer Zelnick Kaufman Beth was granted 72,820 shares and covered exercise/tax liability with 8,803 shares, increasing direct ownership by 38% to 233,102 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Chief Operating Officer Hurlburt Elizabeth was granted 93,010 shares and covered exercise/tax liability with 10,778 shares, increasing direct ownership by 51% to 242,533 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Chief Executive Officer Todisco Joseph was granted 225,900 shares and covered exercise/tax liability with 27,306 shares, increasing direct ownership by 40% to 697,593 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Director Kaplan Myron was granted 30,453 shares, increasing direct ownership by 15% to 231,487 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Director Lefkowitz Steven W was granted 30,453 shares, increasing direct ownership by 32% to 125,951 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Director Dunton Alan W was granted 30,453 shares, increasing direct ownership by 76% to 70,703 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Director Dillione Janet was granted 30,453 shares, increasing direct ownership by 79% to 68,926 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Director Duncan Gregory Scott was granted 30,453 shares, increasing direct ownership by 79% to 68,786 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Director Stewart Robert A was granted 30,453 shares, increasing direct ownership by 85% to 66,453 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Director Dillione Janet sold $68,800 worth of shares (10,000 units at $6.88), decreasing direct ownership by 21% to 38,473 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Chief Operating Officer Hurlburt Elizabeth covered exercise/tax liability with 5,794 shares, decreasing direct ownership by 3% to 160,301 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Chief Executive Officer Todisco Joseph covered exercise/tax liability with 40,082 shares and exercised 29,585 shares at a strike of $3.38, decreasing direct ownership by 2% to 498,999 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Chief Commercial Officer Seckler Michael David was granted 133,156 shares (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- SEC Form 3 filed by new insider Seckler Michael David3 - CorMedix Inc. (0001410098) (Issuer)
- Director Lefkowitz Steven W exercised 15,000 shares at a strike of $5.63, increasing direct ownership by 19% to 95,498 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Chief Operating Officer Hurlburt Elizabeth covered exercise/tax liability with 10,895 shares, decreasing direct ownership by 6% to 166,095 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Chief Legal Officer Zelnick Kaufman Beth covered exercise/tax liability with 11,333 shares, decreasing direct ownership by 6% to 169,085 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Director Dunton Alan W exercised 20,000 shares at a strike of $4.03 and sold $260,000 worth of shares (20,000 units at $13.00) (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Chief Executive Officer Todisco Joseph sold $360,000 worth of shares (30,000 units at $12.00) and exercised 30,000 shares at a strike of $4.43 (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Director Dillione Janet exercised 34,000 shares at a strike of $7.82 and sold $408,000 worth of shares (34,000 units at $12.00) (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Director Lefkowitz Steven W sold $475,200 worth of shares (40,000 units at $11.88), decreasing direct ownership by 33% to 80,498 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Director Dillione Janet exercised 46,657 shares at a strike of $3.96 and sold $466,570 worth of shares (46,657 units at $10.00) (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Director Dillione Janet exercised 26,343 shares at a strike of $3.64 and sold $261,586 worth of shares (26,343 units at $9.93) (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Director Dillione Janet sold $342,600 worth of shares (30,000 units at $11.42), decreasing direct ownership by 38% to 48,473 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Director Kaplan Myron bought $275,500 worth of shares (25,000 units at $11.02), increasing direct ownership by 14% to 201,034 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Director Duncan Gregory Scott exercised 13,333 shares at a strike of $8.32, increasing direct ownership by 53% to 38,333 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Director Dunton Alan W exercised 10,000 shares at a strike of $3.55 and sold $131,300 worth of shares (10,000 units at $13.13) (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Chief Executive Officer Todisco Joseph exercised 50,000 shares at a strike of $3.47 and sold $650,000 worth of shares (50,000 units at $13.00) (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Chief Executive Officer Todisco Joseph covered exercise/tax liability with 21,225 shares, decreasing direct ownership by 4% to 509,496 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- New insider Cormedix Inc. claimed ownership of 9,090,909 shares (SEC Form 3)3 - CorMedix Inc. (0001410098) (Reporting)
- Chief Legal Officer Zelnick Kaufman Beth exercised 50,000 shares at a strike of $3.30 and sold $670,264 worth of shares (50,000 units at $13.41) (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Chief Operating Officer Hurlburt Elizabeth exercised 53,997 shares at a strike of $1.45 and sold $711,817 worth of shares (53,997 units at $13.18) (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Amendment: Chief Operating Officer Hurlburt Elizabeth covered exercise/tax liability with 8,424 shares, decreasing direct ownership by 5% to 176,990 units (SEC Form 4)4/A - CorMedix Inc. (0001410098) (Issuer)
- Amendment: Chief Legal Officer Zelnick Kaufman Beth covered exercise/tax liability with 8,880 shares, decreasing direct ownership by 5% to 180,418 units (SEC Form 4)4/A - CorMedix Inc. (0001410098) (Issuer)
- Chief Operating Officer Hurlburt Elizabeth was granted 69,686 shares, increasing direct ownership by 60% to 185,414 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Chief Legal Officer Zelnick Kaufman Beth was granted 69,686 shares, increasing direct ownership by 58% to 189,298 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Chief Financial Officer Blum Susan was granted 69,686 shares (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- SEC Form 3 filed by new insider Blum Susan3 - CorMedix Inc. (0001410098) (Issuer)
- Director Lefkowitz Steven W exercised 20,000 shares at a strike of $4.03, increasing direct ownership by 20% to 120,498 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Chief Executive Officer Todisco Joseph exercised 59,170 shares at a strike of $3.38, increasing direct ownership by 13% to 530,721 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Chief Executive Officer Todisco Joseph was granted 187,500 shares and covered exercise/tax liability with 23,977 shares, increasing direct ownership by 53% to 471,551 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Director Dunton Alan W was granted 25,000 shares, increasing direct ownership by 164% to 40,250 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Director Stewart Robert A was granted 25,000 shares, increasing direct ownership by 227% to 36,000 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Director Dillione Janet was granted 25,000 shares, increasing direct ownership by 47% to 78,473 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Director Kaplan Myron was granted 25,000 shares, increasing direct ownership by 17% to 176,034 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Director Lefkowitz Steven W was granted 25,000 shares, increasing direct ownership by 33% to 100,498 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Director Duncan Gregory Scott was granted 25,000 shares (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Chief Financial Officer David Matthew T covered exercise/tax liability with 6,515 shares, decreasing direct ownership by 6% to 95,270 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Chief Executive Officer Todisco Joseph covered exercise/tax liability with 17,829 shares, decreasing direct ownership by 5% to 308,028 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- EVP, Chief Commercial Officer Mistry Erin covered exercise/tax liability with 5,689 shares, decreasing direct ownership by 5% to 100,992 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- EVP Hurlburt Elizabeth covered exercise/tax liability with 5,790 shares, decreasing direct ownership by 5% to 115,728 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- EVP, Chief Commercial Officer Mistry Erin was granted 62,500 shares and covered exercise/tax liability with 7,830 shares, increasing direct ownership by 105% to 106,681 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Chief Legal Officer Zelnick Kaufman Beth was granted 87,500 shares and covered exercise/tax liability with 11,844 shares, increasing direct ownership by 172% to 119,612 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Chief Financial Officer David Matthew T was granted 62,500 shares and covered exercise/tax liability with 8,648 shares, increasing direct ownership by 112% to 101,786 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- EVP Hurlburt Elizabeth was granted 87,500 shares and covered exercise/tax liability with 11,378 shares, increasing direct ownership by 168% to 121,519 units (SEC Form 4)4 - CorMedix Inc. (0001410098) (Issuer)
- Amendment: Chief Legal Officer Zelnick Kaufman Beth covered exercise/tax liability with 6,044 shares, decreasing direct ownership by 12% to 43,956 units (SEC Form 4)4/A - CorMedix Inc. (0001410098) (Issuer)